Yes, aspirin can and should be started immediately in suspected Kawasaki disease, even before IVIG is available.
The standard treatment approach is to administer high-dose aspirin (80-100 mg/kg/day) together with IVIG (2 g/kg), but aspirin can be initiated while awaiting IVIG administration. 1 The guidelines consistently describe aspirin as being given "with IVIG" during the acute phase, but this reflects concurrent therapy rather than a requirement to withhold aspirin until IVIG arrives.
Rationale for Early Aspirin Initiation
The American Heart Association guidelines and ACCP recommendations establish that aspirin serves dual purposes in Kawasaki disease:
- High-dose aspirin (80-100 mg/kg/day) provides anti-inflammatory effects during the acute febrile phase 2
- Low-dose aspirin (3-5 mg/kg/day) provides antiplatelet effects after fever resolution 1
High-dose aspirin and IVIG appear to have an additive anti-inflammatory effect 1, meaning they work through complementary mechanisms rather than aspirin being dependent on IVIG for efficacy.
Timing Considerations
IVIG should ideally be administered within 10 days of illness onset (preferably within 7 days) 1. However, logistical delays in obtaining IVIG are common. During this window:
- Starting aspirin immediately addresses the inflammatory process
- There is no evidence that aspirin administration before IVIG compromises IVIG effectiveness
- Delaying all treatment while awaiting IVIG unnecessarily prolongs inflammation
Important Caveats
The Aspirin Controversy
Recent evidence challenges the necessity of high-dose aspirin altogether. Multiple studies demonstrate that IVIG alone may be non-inferior to IVIG plus aspirin for preventing coronary artery lesions:
- A 2025 randomized trial showed no significant difference in coronary artery lesion rates between IVIG alone versus IVIG plus aspirin (1.5% vs 2.9% at 6 weeks) 3
- A 2024 Bayesian analysis found only 9.3% probability that high-dose aspirin reduces coronary complications 4
- Multiple retrospective studies show similar outcomes with low-dose or no aspirin 5, 6, 7
However, established guidelines still recommend high-dose aspirin 2, 1, 2, and most centers continue this practice despite emerging evidence questioning its benefit.
Reye Syndrome Risk
Critical safety consideration: Children on aspirin therapy face Reye syndrome risk during influenza or varicella infection 1, 8. Parents must be instructed to contact their physician immediately if the child develops symptoms of or exposure to these infections. Consider substituting clopidogrel or LMWH during active viral illness 8.
Practical Algorithm
For suspected Kawasaki disease:
- Immediately initiate high-dose aspirin (80-100 mg/kg/day divided into 4 doses)
- Arrange IVIG (2 g/kg single infusion) as soon as possible
- Continue high-dose aspirin until either:
- 48-72 hours after fever resolution, OR
- Day 14 of illness AND 48-72 hours afebrile (institutional variation exists) 1
- Transition to low-dose aspirin (3-5 mg/kg/day) and continue until 6-8 weeks if no coronary abnormalities 1
If IVIG is delayed beyond several hours:
- Continue high-dose aspirin
- Do not wait to start anti-inflammatory therapy
- Administer IVIG as soon as available
The key principle is that aspirin initiation should not be delayed by IVIG unavailability, as both agents work through complementary mechanisms and aspirin provides immediate anti-inflammatory benefit while IVIG is being obtained.